Gyon Technologies Capital Management, LP Amicus Therapeutics, Inc. Transaction History

Gyon Technologies Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$6.23 - $11.12 $164,465 - $293,556	26,399 New	26,399 $284,000
Q1 2022 May 12, 2022	SELL	$7.89 - $12.48 $785,102 - $1.24 Million	-99,506 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$9.82 - $12.44 $761,766 - $965,008	77,573 Added 353.68%	99,506 $1.15 Million
Q3 2021 Nov 18, 2021	BUY	$8.74 - $11.84 $191,694 - $259,686	21,933 New	21,933 $209,000
Q1 2020 May 15, 2020	SELL	$6.63 - $11.16 $74,600 - $125,572	-11,252 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$7.48 - $10.75 $84,164 - $120,959	11,252 New	11,252 $110,000

311

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.53B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Gyon Technologies Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Gyon Technologies Capital Management, LP with notifications on news.